These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18713990)

  • 41. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer.
    Redmond WL; Weinberg AD
    Crit Rev Immunol; 2007; 27(5):415-36. PubMed ID: 18197805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
    Mendel I; Shevach EM
    Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
    Dawicki W; Bertram EM; Sharpe AH; Watts TH
    J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
    Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
    Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells.
    Hill JA; Hall JA; Sun CM; Cai Q; Ghyselinck N; Chambon P; Belkaid Y; Mathis D; Benoist C
    Immunity; 2008 Nov; 29(5):758-70. PubMed ID: 19006694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.
    Panda AK; Kim YH; Shevach EM
    J Immunol; 2022 Feb; 208(4):851-860. PubMed ID: 35039334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Central Roles of OX40L-OX40 Interaction in the Induction and Progression of Human T Cell-Driven Acute Graft-versus-Host Disease.
    Tripathi T; Yin W; Xue Y; Zurawski S; Fujita H; Hanabuchi S; Liu YJ; Oh S; Joo H
    Immunohorizons; 2019 Mar; 3(3):110-120. PubMed ID: 31240276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue.
    Piconese S; Timperi E; Pacella I; Schinzari V; Tripodo C; Rossi M; Guglielmo N; Mennini G; Grazi GL; Di Filippo S; Brozzetti S; Fazzi K; Antonelli G; Lozzi MA; Sanchez M; Barnaba V
    Hepatology; 2014 Nov; 60(5):1494-507. PubMed ID: 24756990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. OX40L-JAG1-Induced Expansion of Lineage-Stable Regulatory T Cells Involves Noncanonical NF-κB Signaling.
    Kumar P; Lele SS; Ragothaman VK; Raghunathan D; Epstein AL; Chiba S; Prabhakar BS
    J Immunol; 2019 Dec; 203(12):3225-3236. PubMed ID: 31704879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. OX40 ligation of CD4+ T cells enhances virus-specific CD8+ T cell memory responses independently of IL-2 and CD4+ T regulatory cell inhibition.
    Yu Q; Yue FY; Gu XX; Schwartz H; Kovacs CM; Ostrowski MA
    J Immunol; 2006 Feb; 176(4):2486-95. PubMed ID: 16456009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. OX40-mediated differentiation to effector function requires IL-2 receptor signaling but not CD28, CD40, IL-12Rbeta2, or T-bet.
    Williams CA; Murray SE; Weinberg AD; Parker DC
    J Immunol; 2007 Jun; 178(12):7694-702. PubMed ID: 17548606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.
    Takeda I; Ine S; Killeen N; Ndhlovu LC; Murata K; Satomi S; Sugamura K; Ishii N
    J Immunol; 2004 Mar; 172(6):3580-9. PubMed ID: 15004159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The In Vitro Impact of Glycyrrhizic Acid on CD4+ T Lymphocytes through OX40 Receptor in the Patients with Allergic Rhinitis.
    Fouladi S; Masjedi M; Ghasemi R; G Hakemi M; Eskandari N
    Inflammation; 2018 Oct; 41(5):1690-1701. PubMed ID: 30003405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity.
    Mayer CT; Floess S; Baru AM; Lahl K; Huehn J; Sparwasser T
    Eur J Immunol; 2011 Mar; 41(3):716-25. PubMed ID: 21312192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
    Mayer CT; Tian L; Hesse C; Kühl AA; Swallow M; Kruse F; Thiele M; Gershwin ME; Liston A; Sparwasser T
    J Autoimmun; 2014 May; 50():23-32. PubMed ID: 24075450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IQGAP1 restrains T-cell cosignaling mediated by OX40.
    Okuyama Y; Nagashima H; Ushio-Fukai M; Croft M; Ishii N; So T
    FASEB J; 2020 Jan; 34(1):540-554. PubMed ID: 31914585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Critical, but conditional, role of OX40 in memory T cell-mediated rejection.
    Vu MD; Clarkson MR; Yagita H; Turka LA; Sayegh MH; Li XC
    J Immunol; 2006 Feb; 176(3):1394-401. PubMed ID: 16424166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Soluble OX40L favors tumor rejection in CT26 colon carcinoma model.
    Serebrovskaya EO; Yuzhakova DV; Ryumina AP; Druzhkova IN; Sharonov GV; Kotlobay AA; Zagaynova EV; Lukyanov SA; Shirmanova MV
    Cytokine; 2016 Aug; 84():10-6. PubMed ID: 27203665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.